‘All of Us’ genetics chart stirs unease over controversial depiction of race
By Max Kozlov,
Nature
| 02. 23. 2024
Some geneticists have expressed their unease about a figure in a high-profile Nature paper that was published earlier this week1, noting that it could be misinterpreted as reinforcing racist beliefs. The figure has reignited a long-standing debate among geneticists about how best to discuss and depict race, ethnicity and genomic ancestry, given how these terms can be misinterpreted and weaponized by extremists.
“The problem is, a lot of people will see figures like this as supporting a viewpoint” that race and ethnicity are closely aligned with genetics, says Ewan Birney, deputy director-general of the European Molecular Biology Laboratory in Cambridgeshire, UK. “And then they build castles in the air from all this.”
Alexander Bick, a physician and geneticist at Vanderbilt University Medical Center in Nashville, Tennessee, who co-authored the paper in which the figure appears, acknowledged in an e-mail to Nature’s news team that “it’s clear that the figure fell short of our intended goal for this paper”. (Nature’s news team is editorially independent of its journal team.) But Bick defended the analysis, noting...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Victoria Bisset and Adela Suliman, The Washington Post | 05.09.2024
Photo by CDC from Unsplash
A baby girl born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene therapy trial, Britain’s National Health Service said Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the first...
By Carrie Arnold, Nature Biotechnology | 04.17.2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to...
By Charlotte Hu, Vox | 05.06.2024
Medicine has entered a new era in which scientists have the tools to change human genetics directly, creating the potential to treat or even permanently cure diseases by editing a few strands of troublesome DNA. And CRISPR, the gene-editing...